SR9009 is marketed and used in performance settings for endurance enhancement and fat loss, specifically as an alternative to Cardarine after Cardarine's cancer findings became widely known. The appeal is the same — improved endurance and fat oxidation without androgenic effects. The fundamental problem is that the human oral bioavailability questi...
SR9009 appears in stacks alongside SARMs or traditional anabolics as an endurance and fat loss addition. It is most commonly combined with Ostarine or RAD-140 in users who want the full SARM-plus-metabolic-enhancer experience. Given the bioavailability uncertainty, its contribution to any stack is genuinely unknown....
The primary risk with SR9009 is the complete absence of human safety data combined with the bioavailability uncertainty. If it is not bioavailable orally, users are wasting money and ingesting an untested compound with no benefit. If it is bioavailable, the safety profile is entirely unknown. Rev-Er...